ASTRONAUTX LIMITED

Active Altrincham

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ASTRONAUTX LIMITED

Research and experimental development on biotechnology

Founded 1 Apr 2019 Active Altrincham, United Kingdom 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 18 Jul 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 10 Apr 2026 Next due 14 Apr 2027 10 months remaining
Net assets £9M £10M 2024 year on year
Total assets £24M £18M 2024 year on year
Total Liabilities £15M £8M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Website

www.example.com

Full company profile for ASTRONAUTX LIMITED (11919384), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 1 Apr 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2019–2024)

Cash in Bank

£21.59M

Increased by £17.03M (+373%)

Net Assets

£8.84M

Increased by £10.42M (+659%)

Total Liabilities

£14.81M

Increased by £7.72M (+109%)

Turnover

£1.10M

Increased by £453.52k (+70%)

Employees

5

Increased by 1 (+25%)

Debt Ratio

63%

Decreased by 66 (-51%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 2Apr 2019Seed
Investor 3Apr 2019Seed, Series A
Investor 1Mar 2020Seed

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 62,386,905 Shares £58.34m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Jan 202618,000,000£18.00m£1
15 Dec 2025545,818£54.582£0
21 Nov 202569,977£6.998£0
22 Jul 2025130,970£13.097£0
20 Dec 202418,000,000£18.00m£1

Officers

Officers

3 active
Status
Corrigan, Mark Herman, Dr.DirectorAmericanUnited States681 Feb 2024Active
Timothy Peter Warren EdwardsDirectorBritishUnited Kingdom6919 Sept 2019Active
Uteng, Marianne, DrDirectorNorwegianSwitzerland4817 Aug 2023Active

Shareholders

Shareholders (39)

Novartis Bioventures Ltd
16.0%
10,000,000
Mpm Bioventures 2022, Lp
16.0%
10,000,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 4 Ceased

Dementia Discovery Gp Lp

Ceased 20 Dec 2024

Ceased

Sv Health Managers Llp

Ceased 12 Jul 2024

Ceased

David Reynolds

Ceased 2 Mar 2020

Ceased

Ruth Mckernan

Ceased 2 Mar 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026Confirmation StatementConfirmation statement made on 31 Mar 2026 with updates
17 Feb 2026CapitalAllotment of shares (GBP 6,260.6176) on 27 Jan 2026
15 Dec 2025CapitalAllotment of shares (GBP 4,460.6176) on 15 Dec 2025
11 Dec 2025CapitalAllotment of shares (GBP 4,406.0358) on 21 Nov 2025
11 Dec 2025CapitalAllotment of shares (GBP 4,399.0381) on 22 Jul 2025
10 Apr 2026 Confirmation Statement

Confirmation statement made on 31 Mar 2026 with updates

17 Feb 2026 Capital

Allotment of shares (GBP 6,260.6176) on 27 Jan 2026

15 Dec 2025 Capital

Allotment of shares (GBP 4,460.6176) on 15 Dec 2025

11 Dec 2025 Capital

Allotment of shares (GBP 4,406.0358) on 21 Nov 2025

11 Dec 2025 Capital

Allotment of shares (GBP 4,399.0381) on 22 Jul 2025

Recent Activity

Latest Activity

Confirmation statement made on 31 Mar 2026 with updates

1 months ago on 10 Apr 2026

Allotment of shares (GBP 6,260.6176) on 27 Jan 2026

3 months ago on 17 Feb 2026

Allotment of shares (GBP 4,460.6176) on 15 Dec 2025

5 months ago on 15 Dec 2025

Allotment of shares (GBP 4,406.0358) on 21 Nov 2025

5 months ago on 11 Dec 2025

Allotment of shares (GBP 4,399.0381) on 22 Jul 2025

5 months ago on 11 Dec 2025